Skip to main content
HealthReportedMedium
4.8

Helus psychedelic depression drug shows efficacy but safety concerns emerge

Helus Pharma's psychedelic drug improved depression in a clinical study, but the trial reported serious adverse events, raising safety questions. The efficacy signal is promising, but the safety profile may complicate regulatory approval and market prospects.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

STAT News2 days agoengCredibility 19%View source

Score Breakdown

Mosaic Score4.8
Model confidence0.5
Significance0.5
Source credibility0.2
Source

Related signals

8 found